Hanita Lenses (עדשות חניתה), the cataract-lens maker founded by Kibbutz Hanita 50 meters from the Lebanese border, is now fully owned by the Chinese fund Rimonci, led by Rachel Liu. The fund bought 80 percent for $35 million, then the remaining stake for $6 million in June 2026. Since the war, the company has moved its Israeli plant, cut staff from 80 to 25 and opened a second factory in China.
Last updated: November 14, 2026
What is Hanita Lenses?
Hanita Lenses is an Israeli manufacturer of intraocular lenses, the artificial lenses surgeons implant during cataract surgery. Kibbutz Hanita, in the western Galilee, founded it shortly after the First Lebanon War of 1982, according to a Calcalist magazine feature published on November 12, 2026.
The idea was modest. The kibbutz founders had grown too old to carry banana bunches in the fields, so they looked for light, non-physical work. A team of four members traveled to Germany to learn contact-lens making from Wöhlk, then a leading producer, and the plant opened with kibbutz members as every worker and manager.
For about 20 years the plant made custom hard contact lenses. In the early 2000s disposable lenses became the standard, local production stopped paying, and importers flooded the market. Yoram Gonen, the plant's former chief executive, told Calcalist that the factory was in fast decline at that point.
The way out was a switch to medical lenses. Hanita began producing intraocular lenses, including multifocal designs, lenses covering a full range of vision, and a model called Intensity with five focal points. That moved the company into a market dominated by much larger groups. Tomer Kisos, the former chief financial officer, described the result as steady and modest: a profit most years, taxes paid, a little saved, but no unicorn.
Why did Kibbutz Hanita sell the factory?
Kibbutz Hanita sold 80 percent of Hanita Lenses to the Chinese fund Rimonci for $35 million, because the plant needed investment the kibbutz did not want to fund and because fewer kibbutz members worked there each year. Calcalist reported that $25 million of the price went to the kibbutz and the rest was placed in the company.
The board began weighing a sale or an outside investor in 2021. Nathan Hilton, the plant's sales representative and a former kibbutz member, said the kibbutz had sold its waterproofing-membrane factory Kotleb to an American corporation in 2017. Kotleb had paid dividends for years while the lens plant paid none, which made members reluctant to keep funding it.
Rimonci had wanted to invest years earlier, citing an aging population and rising cataract surgery numbers, but those talks stalled. In 2021 Gonen emailed Rachel Liu, who runs the fund, to ask about entering the Chinese market, and the conversation restarted. The purchase went through, via Liu's holding company Ballet Vision, shortly before the current war.
Gonen gave the broader reason in the interview: many kibbutz factories sold as farming income shrank, the older workers retired, the young left the kibbutz, and the plant came to depend on outside employees. Olam covered that pattern in the kibbutz privatization wave.
| Date | Event | Detail |
|---|---|---|
| Early 1980s | Kibbutz Hanita founds the plant | Four members trained at Wöhlk in Germany |
| 2017 | Kibbutz sells Kotleb | Waterproofing-membrane plant sold to a U.S. corporation |
| 2021 | Talks with Rimonci restart | Board weighs a sale or an investor |
| Before the war | Rimonci buys 80 percent | $35 million, of which $25 million to the kibbutz |
| February 2026 | Kibbutz sues the fund | Claims breach of the promise to buy the rest |
| June 2026 | Settlement | Fund buys the remaining stake for $6 million |
| November 2026 | Calcalist magazine feature | Liu says she will keep Israeli production |
How did the war change production?
Hezbollah fire stopped production at the plant on the first day of the war, and the company then moved its Israeli production out of the kibbutz, according to Calcalist. The Home Front Command barred work at the site because it faced direct fire and had no protected rooms.
Nathan Peretz, the plant's maintenance manager, said staff worked only at night, covered the building to hide the lights, and later obtained a mobile shelter. The company rented a warehouse in Ramat Yishai to hold its large inventory and a production floor in Nesher, where it built a sterile production room from scratch over several months. Medical-device plants need regulatory approvals for every machine move, which made the work slower than relocating an ordinary factory.
Alex Maliarov, the development manager, described the problem as one of sizes. Intraocular lenses are made in power steps, and when stock for one step runs out the surgeon cannot substitute another. The company had to decide which hospitals received a limited number of lenses of a given power.
The plant later moved again, to the Bar-Lev industrial zone. Liu said the company lost about $500,000 a month during the first two years of the war. Her plan had three parts: a second factory in China, planned before the war, the move to Bar-Lev, and cutting staff from 80 to 25. The new sites began operating in 2025.
The kibbutz story sits inside a larger one. Olam tracks the sector in the Kibbutz Industrial Watchlist and the profile of KIBI, the kibbutz industries association, and covered another kibbutz export in the Caesarstone case study.
What did the kibbutz and the fund fight about?
The kibbutz sued Rimonci in February 2026 for failing to complete the purchase of the company to 100 percent, and the two sides settled in June with the fund paying $6 million for the remaining stake. Calcalist reported that the kibbutz's lawsuit said it had been sidelined from management and that the board no longer met.
Relations had worsened as layoffs and the move reached kibbutz members. One member described Liu as dominant and said kibbutz managers felt they had gone from decision makers to people carrying out orders. When Gonen retired as chief executive in December 2025, Liu named no replacement and took the role herself, which led some members to suspect a plan to close the Israeli site.
Miko Oz, the kibbutz business manager, said more than 90 percent of members voted for the second stage of the sale, a rare margin for a kibbutz. He said the kibbutz was commercially at peace with the sale but sorry the plant left, because the war was the reason.
Where does the state compensation stand?
Hanita Lenses asked the Israel Tax Authority's property tax compensation fund for NIS 54 million and has received NIS 17 million, according to Calcalist. The company filed the claim a year and eight months before the article and says it has had no status update.
Liu said she had financed the recovery with a $5.5 million bank loan at 7 percent interest, compared with 2 percent on money she borrows from a Chinese bank, so the company is in effect working to service the loan. She said she wondered whether being a Chinese-owned fund played a part in the delay. The Tax Authority told Calcalist it had reviewed the documents and would respond on the remaining compensation in the coming weeks.
Will Hanita Lenses stay in Israel?
Liu says Hanita Lenses will keep production in Israel and operate two sites that back each other up, with Israel plus China, and a warehouse in France. She rejected the kibbutz members' suspicion that she plans to move the know-how to China and close the Israeli plant.
Her stated plan is to enter 20 more countries within two years and 40 within four, and she refused suggestions to rename the brand. She also said large competitors sell an identical product at up to three times the price, so the company will need to educate the market. Hilton said doctors who know him still think of China when they hear the brand and ask where the plant is going.
What would settle the question is concrete: the headcount in Israel after the 2025 restart, the compensation decision from the Tax Authority, and whether the board of directors, which the kibbutz said no longer meets, is reconvened.
Frequently asked questions
Who owns Hanita Lenses?
Rimonci, a Chinese fund led by Rachel Liu, owns the company through the holding company Ballet Vision. It bought 80 percent for $35 million and the remaining stake for $6 million in June 2026.
What does Hanita Lenses make?
The company makes intraocular lenses implanted in cataract surgery, including multifocal lenses and a five-focal-point model called Intensity.
Where is the factory now?
Production moved from Kibbutz Hanita, 50 meters from the Lebanese border, to the Bar-Lev industrial zone, with a second site in China. A rented floor in Nesher was used in the interim.
How many people work at Hanita Lenses?
Staff fell from 80 to 25 after the war, according to Calcalist. The last kibbutz member still working there is Tuvia Livne, aged 74.
Who runs Hanita Lenses?
Rachel Liu, who is 50 and runs Rimonci, has been the company's chief executive since Yoram Gonen retired in December 2025.
Sources
Calcalist magazine, Diana Bahur-Nir, feature on Hanita Lenses (November 12, 2026), the source of the figures and statements above. Olam coverage of the kibbutz industrial sector is linked in the body.
How we report: Olam stories draw on public filings, company disclosures and named sources, checked by our editors. Read our methodology · Corrections








